David M. Preston is Chairman of TRx Pharma, an RTP company founded in 2005. Previously, he was founder of Victory Pharma, a San Diego-based specialty pharmaceutical company and co-founder of DJ Pharma, a specialty pharmaceutical compnay which was acquired in 2000 by Biovail Corporation.
Mr. Preston has 25 plus years of experience as a pharmaceutical executive in sales, marketing and operations, both domestically and internationally, beginning with Eli Lilly and Co. and more recently with Glaxo Wellcome. He has been responsible for the launch of two billion-dollar-plus brands in the U.S. pharmaceutical marketplace.
Mr. Preston is a registered pharmacist and a graduate of the UNC School of Pharmacy.
No comments:
Post a Comment